Yifeng Pharmary(SH:603939) Xin Lang Cai Jing·2025-11-21 01:28Core Insights - Yifeng Pharmacy's stock price decreased by 1.17% on November 20, with a trading volume of 84.52 million yuan [1] - The company reported a financing net buy of -4.18 million yuan on the same day, indicating more financing repayment than new purchases [1] - As of November 20, the total financing and securities lending balance for Yifeng Pharmacy was 109 million yuan [1] Financing Summary - On November 20, Yifeng Pharmacy had a financing buy amount of 6.80 million yuan, with a current financing balance of 107 million yuan, representing 0.37% of the circulating market value [1] - The financing balance is above the 60th percentile level over the past year, indicating a relatively high position [1] - In terms of securities lending, Yifeng Pharmacy repaid 1,900 shares and sold 3,000 shares on November 20, with a selling amount of 71,200 yuan [1] - The securities lending balance was 2.22 million yuan, which is below the 10th percentile level over the past year, indicating a low position [1] Company Performance - As of September 30, Yifeng Pharmacy had 20,200 shareholders, a decrease of 6.41% from the previous period [2] - The company achieved a revenue of 17.29 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 0.39% [2] - The net profit attributable to the parent company was 1.23 billion yuan, showing a year-on-year increase of 10.27% [2] - Since its A-share listing, Yifeng Pharmacy has distributed a total of 2.85 billion yuan in dividends, with 1.95 billion yuan distributed over the past three years [2] Shareholder Structure - As of September 30, 2025, Hong Kong Central Clearing Limited was the second-largest circulating shareholder, holding 199 million shares, a decrease of 38.19 million shares from the previous period [2] - Southern CSI 500 ETF ranked as the seventh-largest circulating shareholder with 8.81 million shares, down by 173,100 shares [2] -交银新成长混合 (Jiaoyin New Growth Mixed) entered the top ten circulating shareholders with 8.45 million shares, while 中欧医疗健康混合A (Zhongou Medical Health Mixed A) exited the list [2]